Our meta‐analysis showed that anti‐PD‐1 antibodies plus chemotherapy significantly improved PFS compared to chemotherapy alone in the first‐line treatment of patients with liver metastases of ESCC. The gene discussed is PDCD1; the disease is esophageal squamous cell carcinoma.